PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 501 participants.
Also called NCT03006562
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 501 participants
- Sponsor
- Registry
-
NCT03006562
-
- Other papers using this trial's data
- Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT03006562. Randomized; single masking; primary purpose prevention. Start 2017-07-01 (actual); primary completion 2019-11-01 (actual). Results posted on 2020-02-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
- Acronym
- PREVENTER
- Condition
- Prostate Cancer
- Condition
- Venous Thromboembolism
- Condition
- Lymphocele After Surgical Procedure
- Condition
- Deep Venous Thrombosis
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Subcutaneous Heparin
- Lead sponsor
- Johns Hopkins University
Record details
- Record id
cardio:ct-nct03006562- Content hash
0388d7e0f0585e674c3002f05a1f8b097c05a077159299a93c948f8bb9f16b72